TELA Bio Inc

Research TELA Bio Inc (TELA) on Bullrun: market cap USD 36.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 36.76M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 80.28M-USD 38.80M-USD 28.67M67.7%-0.83USD 50.85MUSD 55.65MUSD 6.31M
FY2024USD 69.30M-USD 37.80M-USD 42.58M67.1%-1.33USD 52.67MUSD 41.12MUSD 28.46M
FY2023USD 58.45M-USD 46.70M-USD 41.47M68.6%-2.04USD 46.73MUSD 40.52MUSD 18.88M
FY2022USD 41.42M-USD 44.30M-USD 41.62M65.3%-2.72USD 42.02MUSD 39.92MUSD 14.31M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-06USD 36.76Mn/an/an/a
20252025-12-31USD 52.56Mn/an/an/a
20242024-12-31USD 118.98Mn/an/an/a
20232023-12-29USD 162.12Mn/an/an/a
20222022-12-30USD 220.33Mn/an/an/a
20212021-12-31USD 185.98Mn/an/an/a

About TELA Bio Inc

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction;

ETFs that hold TELA Bio Inc

US-listed ETFs

TELA Bio Inc is held by 2 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:

ETFWeightFee
Vanguard Morningstar Total Stock Market ETF (VTI)<0.01%0.03%
Vanguard Extended Market Index Fund ETF Shares (VXF)<0.01%0.05%

Portfolios as filed with the SEC on Form N-PORT, dated June 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is TELA Bio Inc's market cap?

TELA Bio Inc's market capitalization is USD 36.76M.

What does TELA Bio Inc do?

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.